Patients with diabetes who undergo percutaneous coronary intervention (PCI) are at high risk for thrombotic complications following the procedure...
Keywords: Antithrombin, diabetes/metabolic disorders, platelet pharmacology, antiplatelet drugs, direct antithrombin agents
03/2006 | Thrombosis and Haemostasis, Schattauer